MEREO BIOPHARMA GROUP PL-ADR (MREO) Stock Balance Sheet
USA - NASDAQ:MREO - US5894921072 - ADR
1.84 USD
+0.02 (+1.1%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | 2.74M | 6.33M | 93.70M | |||
| Cash Equivalents | null | 69.80M | 57.42M | 61.82M | 127.57M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | 3.25M | 1.47M | 2.55M | 3.23M | 3.01M | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 2.05M | 3.49M | 3.79M | 3.78M | 3.79M | |||
| Total Current Assets | 61.42M | 74.76M | 63.76M | 75.16M | 134.38M | |||
| Non-Current Assets | ||||||||
| PPE Net | 740.00K | 984.00K | 1.65M | 2.21M | 3.42M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | 470.00K | 643.00K | 1.09M | 29.17M | 27.27M | |||
| Other Non-Current Assets | null | null | null | null | null | |||
| Total Non-Current Assets | 1.21M | 1.63M | 2.74M | 31.39M | 30.69M | |||
| TOTAL ASSETS | 62.63M | 76.39M | 66.50M | 106.55M | 165.07M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 0 | 5.54M | 0 | 13.97M | 842.00K | |||
| Accrued Expenses | 5.45M | 4.51M | 5.74M | 5.43M | 5.18M | |||
| Accounts Payable | 1.14M | 2.44M | 2.35M | 3.49M | 3.38M | |||
| Other Current Liabilities | 966.00K | 1.36M | 1.40M | 6.96M | 3.78M | |||
| Total Current Liabilities | 7.56M | 13.85M | 9.49M | 29.85M | 13.18M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 4.39M | 1.48M | 21.83M | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 897.00K | 1.57M | 2.08M | 376.00K | 11.39M | |||
| Total Non-Current Liabilities | 897.00K | 1.57M | 6.48M | 1.85M | 33.22M | |||
| TOTAL LIABILITIES | 8.45M | 15.42M | 15.96M | 31.71M | 46.39M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -486.64M | -462.88M | -419.63M | -231.15M | -216.49M | |||
| Additional Paid In Capital | 546.33M | 539.64M | 486.11M | 307.63M | 334.79M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 3.13M | 3.06M | 2.77M | 2.27M | 2.37M | |||
| Treasury Stock | null | 0 | -1.23M | null | null | |||
| Other Shareholders' Equity | -8.64M | -18.85M | -17.48M | -3.90M | -2.00M | |||
| Shares Outstanding | 158.12M | 154.29M | 139.47M | 124.29M | 116.33M | |||
| Tangible Book Value per Share | 0.0676 | 0.0778 | 0.0705 | 0.0731 | 0.1563 | |||
| Total Shareholders' Equity | 54.18M | 60.97M | 50.54M | 74.84M | 118.67M | |||
| TOTAL LIABILITIES AND EQUITY | 62.63M | 76.39M | 66.50M | 106.55M | 165.07M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.09 | 0.02 | 0.18 | |||
| Current Ratio | 8.13 | 5.40 | 6.72 | 2.52 | 10.20 | |||
| Return On Assets (ROA) | -79.29% | -56.62% | -44.31% | -39.54% | 10.60% | |||
| Return On Equity (ROE) | -91.67% | -70.94% | -58.31% | -56.29% | 14.74% | |||
All data in USD , ROIC based on taxRate of 0.21